Source comparison
Telehealth Clinicians BPC-157 Protocol: Comparison Table
Before writing a protocol, clinicians must choose between three structural models. Each optimized for different patient populations and oversight constraints. Standard Twice-Daily 250 mcg BID, 12-hour split Patient reconstitutes 5mg vial with 2mL BAC water (la
This comparison does not assign a generated winner or score.
- Before writing a protocol, clinicians must choose between three structural models. Each optimized for different patient populations and oversight constraints.
- Standard Twice-Daily
- 250 mcg BID, 12-hour split
- Patient reconstitutes 5mg vial with 2mL BAC water (lasts ~10 days at 250mcg BID)
- Initial 48-hour check-in, then weekly via telehealth portal
- Motivated patients with prior self-injection experience, reliable refrigeration access
- Most widely used. Balances efficacy with manageable oversight burden. Requires patient discipline on timing and storage.
- Single-Dose Pre-Filled
- 500 mcg once daily (evening)
- Pharmacy ships pre-reconstituted syringes in cold packs, patient refrigerates upon arrival
- Initial call only, no ongoing reconstitution oversight needed
- Patients with limited health literacy, inconsistent refrigeration, or high non-compliance risk
- Eliminates reconstitution errors but doubles cost per dose. Useful for patients who failed standard protocol due to prep errors.
- Hybrid Low-Dose
- 250 mcg once daily (morning only)
- Patient reconstitutes 2.5mg vial with 2mL BAC water (lasts ~20 days at 250mcg QD)
- Biweekly check-ins, less frequent than BID model
- Chronic low-grade injuries (tendinopathy, joint pain), patients seeking maintenance rather than acute recovery
- Lower efficacy ceiling but better compliance for patients unable to commit to twice-daily injections. Serum levels drop significantly between doses.